These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Efficacy of lenalidomide in refractory lupus pernio. Dalm VA; van Hagen PM JAMA Dermatol; 2013 Apr; 149(4):493-4. PubMed ID: 23715134 [No Abstract] [Full Text] [Related]
7. Cyclosporin combined with methotrexate in two patients with recalcitrant subacute cutaneous lupus erythematosus. Klein A; Vogt T; Wenzel SM; Fleck M; Landthaler M Australas J Dermatol; 2011 Feb; 52(1):43-7. PubMed ID: 21332692 [TBL] [Abstract][Full Text] [Related]
8. Lenalidomide treatment of cutaneous lupus erythematosus: the Mayo Clinic experience. Kindle SA; Wetter DA; Davis MD; Pittelkow MR; Sciallis GF Int J Dermatol; 2016 Aug; 55(8):e431-9. PubMed ID: 26873674 [TBL] [Abstract][Full Text] [Related]
10. A case of herpes zoster during pimecrolimus use for the treatment of subacute cutaneous lupus erythematosus. Tatlican S; Eren C; Atacan D; Dalgic U; Canpolat F; Eskioglu F J Dermatolog Treat; 2010 Sep; 21(5):322-3. PubMed ID: 19832287 [No Abstract] [Full Text] [Related]
11. Rapid improvement of subacute cutaneous lupus erythematosus with low-dose methotrexate. Böhm L; Uerlich M; Bauer R Dermatology; 1997; 194(3):307-8. PubMed ID: 9187859 [No Abstract] [Full Text] [Related]
12. Successful ustekinumab treatment in a patient with psoriasis and subacute cutaneous lupus erythematosus. Mazgaj M; Picard-Dahan C; Deschamps L; Marinho E; Estève E; Descamps V Int J Dermatol; 2020 Apr; 59(4):e118-e120. PubMed ID: 31957866 [No Abstract] [Full Text] [Related]
13. Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome. Cortés-Hernández J; Torres-Salido M; Castro-Marrero J; Vilardell-Tarres M; Ordi-Ros J Br J Dermatol; 2012 Mar; 166(3):616-23. PubMed ID: 21999437 [TBL] [Abstract][Full Text] [Related]